Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
목요일, 8월 27

Cardinal Health Inc

CAHNYSE
Trade with Public
Trade with Public
$238.40
0.480.2%
가까이에: Aug 26, 5:00 PM EST
$238.40
N/A
시간외: 4:25 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황배당금비교주식 보고서

Cardinal Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Cardinal Health (CAH).

Price Target Range — 12 Quarters

Analyst Consensus — 17 Analysts

15Buy
2Hold
Consensus RatingBuy# Analysts17Avg. Consensus PT$224Upside to Avg. PT-6.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 19, 2026RBC CapitalRyan HalstedInitiateOutperform$276
Aug 13, 2026TD CowenCharles RhyeePT RaiseBuy$275→$280
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
RBC Capital Initiates Coverage On Cardinal Health with Outperform Rating, Announces Price Target of $276

RBC Capital analyst Ryan Halsted initiates coverage on Cardinal Health (NYSE:CAH) with a Outperform rating and announces Price Target of $276.
Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $280

TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $275 to $280.
Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $260

JP Morgan analyst Lisa Gill maintains Cardinal Health (NYSE:CAH) with a Neutral and raises the price target from $215 to $260.
Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Cardinal Health, Raises Price Target to $275

Barclays analyst Glen Santangelo maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $258 to $275.
Benzinga Newsdesk

PRO
Evercore ISI Group Maintains Outperform on Cardinal Health, Raises Price Target to $270

Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $265 to $270.
Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $265

Morgan Stanley analyst Erin Wright maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $255 to $265.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved